Search

Gerresheimer AG

Deschisă

SectorSănătate

66.45 -2.21

Rezumat

Modificarea prețului

24h

Curent

Minim

64.75

Maxim

69.4

Indicatori cheie

By Trading Economics

Venit

11M

38M

Vânzări

70M

569M

P/E

Medie Sector

22.028

63.778

EPS

1.63

Randament dividend

1.71

Marjă de profit

6.731

Angajați

12,142

EBITDA

16M

117M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+49.53% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.71%

2.39%

Următoarele câștiguri

11 apr. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-382M

2.4B

Deschiderea anterioară

68.66

Închiderea anterioară

66.45

Sentimentul știrilor

By Acuity

16%

84%

28 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Gerresheimer AG Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 mai 2024, 11:16 UTC

Top știri

German Companies Bet on AI But Payoff Could Be Years Away -- Talking Markets

Gerresheimer AG Așteptări

Obiectiv de preț

By TipRanks

49.53% sus

Prognoză pe 12 luni

Medie 102.73 EUR  49.53%

Maxim 122.5 EUR

Minim 93 EUR

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruGerresheimer AG - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

13 ratings

12

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

67.9 / 74.9Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

28 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.